ORIGINAL ARTICLE |
|
Year : 2022 | Volume
: 4
| Issue : 2 | Page : 146-149 |
|
Correlation of depression and anxiety in type 2 diabetes mellitus patients in a tertiary care hospital
Ashok Kamat1, Laxmi Kamat2
1 Department of Psychiatry, KAHER Institute of Nursing Sciences, Belagavi, Karnataka, India 2 Department of Obstetrics and Gynecology, KAHER Institute of Nursing Sciences, Belagavi, Karnataka, India
Correspondence Address:
Dr. Ashok Kamat KAHER Institute of Nursing Sciences, Belagavi, Karnataka India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/ijptr.ijptr_16_22
|
|
Context: People with type 2 diabetes are more likely than the general population to have depressive And anxiety symptoms. Type 2 diabetics are being studied for depression and anxiety.
Aim: To investigate the Prevalence and correlates of Depression and Anxiety in Type 2 Diabetes Mellitus Patients.
Settings and Design: The Department of Endocrine and Medicine at Vijaya Hospital in Belagavi, South India, did a descriptive research.
Methods and Materials: In a study on depression and anxiety, 384 people with type 2 diabetes were administered the Hospital Anxiety and Depression Scale (HADS).
Statistical analysis used: Descriptive and inferential statistical analysis were done using SPSS software.
Results: Depression and anxiety were found in 32.56% and 37.76% of the 384 patients assessed, respectively. P = 0.0001 showed a strong connection between anxiety and depressive symptoms (r = 0.7046) in this study. Type 2 diabetes duration, type of therapy and HADS-Anxiety were known to have a significant association. HADS-Depression revealed a significant association with age, qualification, type 2 diabetes duration, and treatment type (P < 0.05) in the same way as HADS-Depression does.
Conclusion: According to the findings of this study, anxiety and sadness are widespread among people with type 2 diabetes. Furthermore, a strong link between depression and anxiety was observed across a wide range of variables. Depression and anxiety symptoms in people with type 2 diabetes should be assessed and treated on a frequent basis.
|
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|